Safety and Efficacy of Fingolimod and Natalizumab in Multiple Sclerosis After the Failure of First-Line Therapy: Single Center Experience Based on the Treatment of Forty-Four Patients.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Przemyslaw Puz Anetta Lasek-Bal |
| Publication date | November 10, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |